compound semaglutide not working Why Compounded Isn't Compounded' weight-loss drugs are a

Tirzepatide (Mounjaro / Zepbound / compounded) Similar stability to semaglutide

individual results vary Tirzepatide (Zepbound): In large clinical trials, average weight loss was meaningful over roughly 72 weeks when combined with lifestyle modifications

SURMOUNT-1 (NEJM, 2022) the Tirzepatide Phase 3 trial enrolled 2,539 participants

95% medication adherence in the first month 84% of prescribed patients engage with in-app content 56% use Med Tracker (where side effects can also be tracked) 56% engage in meal logging, with an average of 35 meals logged in the first month Patients log weight 1-2 times per week, on average, over the first 8 weeks of treatment Patients use Noom Move workouts an average of 6.9 times in the first month 45% engage with side-effect support in Nooms "Success Kit" Noom appreciates the potential of the new PDURS framework because it provides a way to put a software product on the drug label in an evidence-based way

Studies suggest that tirzepatide-based medication may lead to greater weight loss than semaglutide-based medication